The American Society of Clinical Oncology estimates that 56,460 adults in the United States (13,250 men and 43,210 women) will be diagnosed with thyroid cancer this year. It is currently the fastest-growing cancer in America. How much is due to an increase in surveillance or screenings and how much is due to a biological change in disease prevalence is uncertain. The lack of symptoms also means that, in some cases, the disease progresses to advanced stages before people are aware they have a thyroid problem. Read More
Posts written by Mark Urken, MD
Mark L. Urken, MD, is one of the foremost authorities on head and neck and thyroid cancer in the world. He has authored numerous textbooks and hundreds of peer-reviewed articles, pioneered innovative surgical techniques and spearheaded research. Read more about Mark Urken, MD
Not everyone agrees with the clinical decisions that are made in the management of thyroid cancer. The extent of surgery and the use of postoperative radioactive iodine (thyroid remnant ablation) remain quite controversial. The importance of prophylactic removal of lymph nodes is also frequently debated at national and local meetings. Read More
Why does thyroid cancer—the most rapidly growing cancer in the United States—require a high level of expertise to treat?
The primary treatment for thyroid cancer is the surgical removal of the entire thyroid gland along with associated lymph nodes. Preservation of the nerves of the vocal cords and the parathyroid glands during surgery is critical to a positive outcome. Because of the complexity, it takes a highly experienced surgeon to perform this type of operation. Read More
Thyroid Cancer Care Collaborative brings an idea to life that could revolutionize thyroid cancer treatment.
The Thyroid Cancer Care Collaborative (TCCC) is a newly developed relational database that could enhance and revolutionize how thyroid cancer is treated. Read More